(+852) 2896-4489

For 20 years, I-OnAsia has been the market leader in Pre-IPO due diligence. Our team covers the China markets extensively. The following...

One of the biggest potential challenges for investors in pre-revenue biotech companies preparing to IPO in Hong Kong may be linked to the...

I apologize profusely to those of you who tinkled regarding my failure to ruminate, at least publicly, over the last few months. Suffice...